My watch list  

107 Current news of Altana


You can refine your search further. Select from the filter options on the left to narrow down your results.

ALTANA opens additives production site in China


Bad Homburg, September 30, 2002 - BYK-Chemie GmbH, Wesel, part of ALTANA Chemie, has recently opened a new production site for paint and plastics additives in Tongling, China. Founded towards the end of 2001, BYK-Chemie (Tongling) Co. Ltd. is responsible for operations at the site and plans to ...


ALTANA: On track to a new record with unabated growth


ALTANA continues to remain on course to success in the third quarter. The excellent first half year business development of ALTANA AG also continued in the third quarter of 2001. Compared to the previous year, profit before taxes of the first nine months remarkably rose by 50% to 350 million ...


ALTANA to establish Genomics Research Center in the US


In the course of its US strategy, Byk Gulden (Constance), the pharmaceuticals division of ALTANA AG, and GPC Biotech (Munich/Martinsried) will form a technology alliance in the fields of genomics/proteomics and bioinformatics. Together with its US subsidiary, ALTANA Inc., Byk Gulden will ...


ALTANA AG Takes Minority Equity Stake in GPC Biotech AG


GPC Biotech AG (Frankfurt Stock Exchange: GPC) announced today that ALTANA (Bad Homburg v. d. H., Germany) will make an equity investment in GPC Biotech of EUR 34.2 million. GPC Biotech will issue 1,690,000 new bearer shares to ALTANA at a purchase price of EUR 20.25 per share. ALTANA will ...


ALTANA expects to achieve record levels in 2001

Offensive research strategies confirmed / Panto successor products in sight


On the occasion of an international analysts and press conference in Bad Homburg, headquarters of ALTANA AG, the Chairman of the Managing Board, Nikolaus Schweickart, confirmed the demanding profit expectations for the whole year 2001: “The ALTANA Group is well on the way towards another ...


ALTANA AG: Profit increase by around 50% in the first half of 2001


Consolidated sales within the first half of the year increased by 24% to 1,136 million euro (previous year: 915 million euro), thus smoothly continuing the dynamic business trend of the past years. Adjusted for exchange rate effects and smaller acquisitions the corresponding operative growth ...


GPC Biotech announces two milestones in expanded anti-microbial alliance with Altana Subsidiary Byk Gulden


GPC Biotech, a leading genomics- and proteomics-driven drug discovery company, today announced the achievement of two milestones by using its Reverse Genomics™ mode-of-action technology in its anti-microbial alliance with Byk Gulden, the pharmaceuticals group of Altana AG (ALT.FSE). The two ...


Page 11 From 11
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE